 - Evidence of clinically significant disease e.g., cardiac, respiratory, gastrointestinal, renal, psychiatric or neurological disease, malignancy other than basal cell carcinoma, or chronic pain or condition that in the opinion of the investigators could affect the participants safety or interfere with the study assessments 